The anti-inflammatory effect of prunus yedoensis bark extract on adipose tissue in diet-induced obese mice

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Kang, Hee ^a   Kwak, Tae Kyung ^a   Kim, Bo Geun ^a   Lee, Kyung Jin ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTIDIABETIC AGENT; GENISTEIN; GLUCOSE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLANT EXTRACT; PROTEIN; PROTEIN F4 80; PRUNETIN; PRUNUS YEDOENSIS EXTRACT; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DIET INDUCED OBESITY; ENZYME REPRESSION; EPIDIDYMIS FAT; GENE; GENE EXPRESSION; GENE REPRESSION; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFLAMMATION; LIPID DIET; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PRUNUS; PRUNUS YEDOENSIS; SRA GENE;

EID: 84941636951     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/937904     Document Type: Article

References (36)

1. H. Xu, G. T. Barnes, Q. Yang, et al, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821-1830, 2003.
2. C. Y. Han, A. Y. Kargi, M. Omer, et al, "Differential effect of saturated and unsaturated free fatty acids on generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes, vol. 59, no. 2, pp. 386-396, 2010.
3. K. Takahashi, S. Mizuarai, H. Araki, et al, "Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. The Journal of Biological Chemistry, vol. 278, no. 47, pp. 46654-46660, 2003.
4. H. Kanda, S. Tateya, Y. Tamori, et al, "MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, "The Journal of Clinical Investigation, vol. 116, no. 6, pp. 1494-1505, 2006.
5. J. M. Stephens, J. Lee, and P. F. Pilch, "Tumor necrosis factor-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. The Journal of Biological Chemistry, vol. 272, no. 2, pp. 971-976, 1997.
6. H. Ruan, N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish, "Tumor necrosis factor-Alpha suppresses adipocytespecific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNFalpha is obligatory. Diabetes, vol. 51, no. 5, pp. 1319-1336, 2002.
7. J. Canton, D. Neculai, and S. Grinstein, "Scavenger receptors in homeostasis and immunity. Nature Reviews Immunology, vol. 13, no. 9, pp. 621-634, 2013.
8. A.M. Lundberg and G. K. Hansson, "Innate immune signals in atherosclerosis. Clinical Immunology, vol. 134, no. 1, pp. 5-24, 2010.
9. K. Fukuhara-Takaki, M. Sakai, Y.-I. Sakamoto, M. Takeya, and S. Horiuchi, "Expression of classAscavenger receptor is enhanced by high glucose in vitro and under diabetic conditions in vivo: one mechanism for an increased rate of atherosclerosis in diabetes. Journal of Biological Chemistry, vol. 280, no. 5, pp. 3355-3364, 2005.
10. N. Rasouli, A. Yao-Borengasser, V. Varma, et al, "Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 9, pp. 1328-1335, 2009.
11. J.-M. Yun, S.-B. Im, M.-K. Roh, et al, "Prunus yedoensis bark inhibits lipopolysaccharide-induced inflammatory cytokine synthesis by I degradation and MAPK activation in macrophages. Journal ofMedicinal Food, vol. 17, no. 4, pp. 407-413, 2014
12. T.-G. Ahn, G. Yang, H.-M. Lee, et al, "Molecular mechanisms underlying the anti-obesity potential of prunetin, an Omethylated isoflavone. Biochemical Pharmacology, vol. 85, no. 10, pp. 1525-1533, 2013.
13. Z. Qin, "The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis, vol. 221, no. 1, pp. 2-11, 2012.
14. K. Traore, M. A. Trush, M. George Jr, E. W. Spannhake, W. Anderson, and A. Asseffa, "Signal transduction of phorbol 12-myristate 13-Acetate (PMA)-induced growth inhibition of human monocytic leukemia THP-1 cells is reactive oxygen dependent. Leukemia Research, vol. 29, no. 8, pp. 863-879, 2005.
15. H. Kang, S.-H. Park, J.-M. Yun, et al, "Effect of cinnamon water extract on monocyte-To-macrophage differentiation and scavenger receptor activity. BMC Complementary and Alternative Medicine, vol. 14, article 90, 2014.
16. M. F. White, "IRS proteins and the common path to diabetes. The American Journal of Physiology-Endocrinology and Metabolism, vol. 283, no. 3, pp. E413-E422, 2002.
17. R. S. Hundal, K. F. Petersen, A. B. Mayerson, et al, "Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. The Journal of Clinical Investigation, vol. 109, no. 10, pp. 1321-1326, 2002.
18. D. N. Kiortsis, A. K. Mavridis, S. Vasakos, S. N. Nikas, and A. A. Drosos, "Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Annals of the Rheumatic Diseases, vol. 64, no. 5, pp. 765-766, 2005.
19. M. A. Gonzalez-Gay, J. M. De Matias, C. Gonzalez-Juanatey, et al, "Anti-Tumor necrosis factor- blockade improves insulin resistance in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, vol. 24, no. 1, pp. 83-86, 2006.
20. J. Xu, H. Morinaga, D. Oh, et al, "GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity. Journal of Immunology, vol. 189, no. 4, pp. 1992-1999, 2012.
21. S. Cinti, G. Mitchell, G. Barbatelli, et al, "Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research, vol. 46, no. 11, pp. 2347-2355, 2005.
22. X. Zhu, G. Zong, L. Zhu, et al, "Deletion of class A scavenger receptor deteriorates obesity-induced insulin resistance in adipose tissue. Diabetes, vol. 63, no. 2, pp. 562-577, 2014.
23. L. Cai, Z. Wang, A. Ji, J. M. Meyer, and D. R. van der Westhuyzen, "Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesity. PLoS ONE, vol. 7, no. 5, Article ID e36785, 2012.
24. D. M. Mosser and J. P. Edwards, "Exploring the full spectrum of macrophage activation. Nature Reviews Immunology, vol. 8, no. 12, pp. 958-969, 2008.
25. J. G. Villanova, J. L. D. Lucena, N. F. ArcÁas, and A. R. Engel, "Increased expression of scavenger receptor type I gene in human peripheral blood from hyperlipidemic patients determined by quantitative additive RT-PCR. Biochimica et Biophysica Acta, vol. 1300, no. 2, pp. 135-141, 1996.
26. L. Li, T. Sawamura, and G. Renier, "Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circulation Research, vol. 94, no. 7, pp. 892-901, 2004.
27. A. Scheepens, K. Tan, and J. W. Paxton, "Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes & Nutrition, vol. 5, no. 1, pp. 75-87, 2010.
28. K.D.R. Setchell, N. M. Brown, P. Desai, et al, "Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. Journal of Nutrition, vol. 131, no. 4, pp. 1362S-1375S, 2001.
29. A. J. Hyun, R.K. Ae, Y. C. Hae, and S.C. Jae, "In vitro antioxidant activity of some selected Prunus species in Korea. Archives of Pharmacal Research, vol. 25, no. 6, pp. 865-872, 2002.
30. J. Lee, G. Yang, K. Lee, et al, "Anti-inflammatory effect of Prunus yedoensis through inhibition of nuclear factor-kappaB in macrophages. BMC Complementary and Alternative Medicine, vol. 13, article 92, 2013.
31. Z. Yang, K. Kulkarni, W. Zhu, and M. Hu, "Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. Anti-Cancer Agents inMedicinal Chemistry, vol. 12, no. 10, pp. 1264-1280, 2012.
32. M. Hu, K. Krausz, J. Chen, et al, "Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones. DrugMetabolism and Disposition, vol. 31, no. 7, pp. 924-931, 2003.
33. S. Kim, I. Sohn, Y. S. Lee, and Y. S. Lee, "Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. Journal of Nutrition, vol. 135, no. 1, pp. 33-41, 2005.
34. Y. M. Lee, J. S. Choi, M. H. Kim, M. H. Jung, Y. S. Lee, and J. Song, "Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition, vol. 22, no. 9, pp. 956-964, 2006.
35. S. Jeon, Y.-J. Park, and Y. H. Kwon, "Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE-/- mice fed a high-fat diet. Molecular Nutrition & Food Research, vol. 58, no. 4, pp. 830-841, 2014.
36. A. C. Toledo, C. P. P. Sakoda, A. Perini, et al, "Flavonone treatment reverses airway inflammation and remodelling in an asthma murine model. British Journal of Pharmacology, vol. 168, no. 7, pp. 1736-1749, 2013.